Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000904454-20-000590)

Filing Details

Accession Number:: 0000904454-20-000590
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-20 18:22:37
Reporting Period:: 2020-08-18

Accepted Time:: 2020-08-20 18:22:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1000694	Novavax Inc	NVAX	Biological Products, (No Disgnostic Substances) (2836)	222816046

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1051997	Jr A Michael Mcmanus	C/O Novavax, Inc. 21 Firstfield Road Gaithersburg MD 20878		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-08-18	4,000	$27.60	13,951	No	4	M	Direct
Common Stock	Acquisiton	2020-08-18	4,000	$27.60	17,951	No	4	M	Direct
Common Stock	Disposition	2020-08-18	8,000	$146.00	9,951	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-08-18	4,000	$0.00	4,000	$27.60
Common Stock	Stock Option (Right to Buy)	Disposition	2020-08-18	4,000	$0.00	4,000	$27.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2018-03-16	2027-03-16	No	4	M	Direct
0	2018-12-15	2027-12-15	No	4	M	Direct